电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Acetylated Lysine 抗体

The 小鼠 单克隆 anti-Acetylated Lysine antibody is suitable to detect Acetylated Lysine. It has been validated for WB, ELISA 和 IHC.
Rockland
产品编号 ABIN6655030
Supplier Product No.: 200-301-a97
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Acetylated Lysine 抗体 (ABIN6655030)

抗原

Acetylated Lysine

适用

请咨询

宿主

  • 28
  • 17
小鼠

克隆类型

  • 26
  • 18
单克隆

标记

  • 18
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This Acetylated Lysine antibody is un-conjugated

应用范围

  • 44
  • 34
  • 33
  • 18
  • 15
  • 14
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

克隆位点

7F8
  • Supplier Product No.

    200-301-a97

    Supplier

    Rockland

    原理

    Lysine Acetylated Antibody

    交叉反应 (详细)

    This antibody is known to react with acetylated lysine residues from mammalian and avian sources.

    纯化方法

    This Protein G purified monoclonal antibody reacts with proteins containing acetylated lysine residues and does not detect non-acetylated lysine residues.

    过滤

    Sterile filtered

    免疫原

    This Protein G purified monoclonal antibody was prepared using conventional hybridoma technology after repeated immunizations with acetylated keyhole limpet hemocyanin (KLH).

    亚型

    IgG1
  • 应用备注

    ELISA_Dilution: User Optimized

    Immunohistochemistry_Dilution: 1:200 - 1:1,000

    Western_Blot_Dilution: 1:500 - 1:2,000

    Other: User Optimized

    说明

    This Protein G purified antibody has been tested for use in ELISA, immunohistochemistry and western blotting.  Specific conditions for reactivity should be optimized by the end user.  Approximately 1 μg of antibody is sufficient to detect 20 μg of acetylated chicken erythrocyte histones (sodium butyrate treated) by Western blotting using HRP Gt-a-Mouse IgG (p/n 610-103-121) and chemiluminescent substrate (p/n PICOMAX-110). Antibody provided in PBS pH 7.4.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Buffer: See application note.

    Stabilizer: 50 % (v/v) Glycerol

    Preservative: 0.09 % (w/v) Sodium Azide

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C,-20 °C

    储存方法

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    有效期

    12 months
  • 抗原

    Acetylated Lysine

    别名

    Lysine Acetylated

    物质类

    Chemical

    背景

    Synonyms: acetyl Lysine antibody, Acetylated lysine antibody, Lysine antibody

    Background: Post-translational modifications of proteins play critical roles in the regulation and function of many known biological processes. A common posttranscriptional modification of lysine residues involves acetylation (1). The conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs) (2). Protein posttranslational reversible lysine Nε-acetylation and deacetylation have been recognized as an emerging intracellular signaling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (3). The regulation of protein acetylation status is impaired in the pathologies of cancer and polyglutamine diseases (4). HDACs therefore are promising targets for anticancer drugs currently in development (5).

You are here: